These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1370460)
1. Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells. Walter EI; Ratnoff WD; Long KE; Kazura JW; Medof ME J Biol Chem; 1992 Jan; 267(2):1245-52. PubMed ID: 1370460 [TBL] [Abstract][Full Text] [Related]
2. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. Walter EI; Roberts WL; Rosenberry TL; Ratnoff WD; Medof ME J Immunol; 1990 Feb; 144(3):1030-6. PubMed ID: 1688588 [TBL] [Abstract][Full Text] [Related]
3. An internally positioned signal can direct attachment of a glycophospholipid membrane anchor. Caras IW J Cell Biol; 1991 Apr; 113(1):77-85. PubMed ID: 1706725 [TBL] [Abstract][Full Text] [Related]
4. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Medof ME; Walter EI; Roberts WL; Haas R; Rosenberry TL Biochemistry; 1986 Nov; 25(22):6740-7. PubMed ID: 2432921 [TBL] [Abstract][Full Text] [Related]
5. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. Lublin DM; Coyne KE J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565 [TBL] [Abstract][Full Text] [Related]
6. A glycosylphosphatidylinositol protein anchor from procyclic stage Trypanosoma brucei: lipid structure and biosynthesis. Field MC; Menon AK; Cross GA EMBO J; 1991 Oct; 10(10):2731-9. PubMed ID: 1655402 [TBL] [Abstract][Full Text] [Related]
7. Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59. Ratnoff WD; Knez JJ; Prince GM; Okada H; Lachmann PJ; Medof ME Clin Exp Immunol; 1992 Mar; 87(3):415-21. PubMed ID: 1371955 [TBL] [Abstract][Full Text] [Related]
8. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. Davitz MA; Low MG; Nussenzweig V J Exp Med; 1986 May; 163(5):1150-61. PubMed ID: 2422313 [TBL] [Abstract][Full Text] [Related]
9. Mammalian glycosylphosphatidylinositol-anchored proteins and intracellular precursors. Hirose S; Knez JJ; Medof ME Methods Enzymol; 1995; 250():582-614. PubMed ID: 7651180 [TBL] [Abstract][Full Text] [Related]
10. Inositol acylation of a potential glycosyl phosphoinositol anchor precursor from yeast requires acyl coenzyme A. Costello LC; Orlean P J Biol Chem; 1992 Apr; 267(12):8599-603. PubMed ID: 1314831 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Low MG; Huang KS Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):483-93. PubMed ID: 1835378 [TBL] [Abstract][Full Text] [Related]
13. A nonfunctional sequence converted to a signal for glycophosphatidylinositol membrane anchor attachment. Moran P; Caras IW J Cell Biol; 1991 Oct; 115(2):329-36. PubMed ID: 1717483 [TBL] [Abstract][Full Text] [Related]
14. Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment. Caras IW; Weddell GN Science; 1989 Mar; 243(4895):1196-8. PubMed ID: 2466338 [TBL] [Abstract][Full Text] [Related]
15. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor. Mold C; Walter EI; Medof ME J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997 [TBL] [Abstract][Full Text] [Related]
16. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. Brodbeck WG; Mold C; Atkinson JP; Medof ME J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410 [TBL] [Abstract][Full Text] [Related]
17. In vitro attachment of glycosyl-inositolphospholipid anchor structures to mouse Thy-1 antigen and human decay-accelerating factor. Fasel N; Rousseaux M; Schaerer E; Medof ME; Tykocinski ML; Bron C Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6858-62. PubMed ID: 2476803 [TBL] [Abstract][Full Text] [Related]
18. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044 [TBL] [Abstract][Full Text] [Related]
19. Developmental variation of glycosylphosphatidylinositol membrane anchors in Trypanosoma brucei. Identification of a candidate biosynthetic precursor of the glycosylphosphatidylinositol anchor of the major procyclic stage surface glycoprotein. Field MC; Menon AK; Cross GA J Biol Chem; 1991 May; 266(13):8392-400. PubMed ID: 1850744 [TBL] [Abstract][Full Text] [Related]
20. Binding of GPI-PLD-treated DAF to the surface of Schistosoma mansoni schistosomula. Carvalho EM; Metz CN; Davitz MA; Ramalho-Pinto FJ Braz J Med Biol Res; 1994 Feb; 27(2):457-62. PubMed ID: 7521707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]